Trials / Conditions / Unverricht-Lundborg Disease
Unverricht-Lundborg Disease
4 registered clinical trials studyying Unverricht-Lundborg Disease — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Registry and Natural History Study for Progressive Myoclonus Epilepsy Type 1 (EPM1) NCT06593951 | Boston Children's Hospital | — |
| Unknown | Intravenous Immunoglobulin for Unverricht-Lundborg Disease. NCT03351569 | Azienda Socio Sanitaria Territoriale di Mantova | Phase 3 |
| Completed | Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and Adults NCT00368251 | UCB Pharma | Phase 3 |
| Completed | Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults NCT00357669 | UCB Pharma SA | Phase 3 |